Immunome dips after launching $400 mln stock offering

Immunome

15/12/2025 21:21

** Shares of biotech co Immunome IMNM.O fall 2% post-market to $22.19 as it seeks equity

    ** Bothell, Washington-based IMNM commences $400 mln stock offering

      ** IMNM shares closed up 15.7% at $22.64 on Mon after co said its experimental drug, varegacestat, met main goal in late-stage study for patients with a rare type of tumor

    ** Leerink, J.P. Morgan, TD Cowen, Goldman and Guggenheim are joint bookrunners for the offering

** With ~91.7 mln shares outstanding, co has ~$2.1 bln market cap

** Through Mon, shares up 113% YTD

    ** All 13 analysts rate shares "strong buy" or "buy"; median PT of $32 up from $22 a month ago, per LSEG data

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))